Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
ConditionProstate Cancer Aggressiveness
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age40-80
SponsorImmunis.AI
About this trial
A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.
Eligibility criteria
Qualifiers
Men between 40-80 of age with at least a 10-year life expectancy
All active surveillance protocols are accepted
No PSA limits
Patient is currently on active surveillance with only ONE previous low grade prostate biopsy.
Disqualifiers
Men with symptoms or rising PSA who have not been proven to have cancer by tissue biopsy i.e. men with only negative prostate biopsies.
Patients with a history of a different cancer (except basal cell carcinoma)
Trial design
Treatments tested in this trial
- Subtraction Normalized Expression of Phagocytes Blood Test
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov